While Aβ and tau pathologies remain central to AD pathogenesis, mounting evidence implicates neuroinflammation as a key driver of disease progression, linking immune dysregulation to neuronal dysfunction and cognitive impairment (2). The gene discussed is MAPT; the disease is Alzheimer disease.